NFKB1 and cancer: In fact, cytotoxic cancer therapies frequently activate tumor necrosis factor (TNF) signaling and nuclear factor kappa B (NFκB) [7,11,12,13,14], a transcription factor that mediates the expression of hundreds of genes involved in cancer cell death and survival, inflammation, and immunity [15,16].